GSA Capital Partners LLP raised its holdings in shares of Lemonade, Inc. (NYSE:LMND - Free Report) by 43.3% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 51,195 shares of the company's stock after purchasing an additional 15,458 shares during the period. GSA Capital Partners LLP owned 0.07% of Lemonade worth $1,609,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in LMND. BG Investment Services Inc. bought a new stake in shares of Lemonade during the first quarter valued at approximately $817,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Lemonade during the first quarter valued at approximately $292,000. Hollencrest Capital Management bought a new stake in shares of Lemonade during the first quarter valued at approximately $41,000. Edgestream Partners L.P. bought a new stake in shares of Lemonade during the first quarter valued at approximately $711,000. Finally, CWM LLC grew its position in Lemonade by 30.2% in the 1st quarter. CWM LLC now owns 2,813 shares of the company's stock worth $88,000 after purchasing an additional 653 shares during the period. Institutional investors own 80.30% of the company's stock.
Insider Transactions at Lemonade
In other news, insider John Sheldon Peters sold 6,543 shares of the business's stock in a transaction dated Monday, June 23rd. The shares were sold at an average price of $45.00, for a total value of $294,435.00. Following the sale, the insider directly owned 106,115 shares in the company, valued at $4,775,175. The trade was a 5.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, major shareholder Softbank Group Capital Ltd sold 387,282 shares of the business's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $32.84, for a total transaction of $12,718,340.88. Following the completion of the sale, the insider owned 7,111,441 shares in the company, valued at approximately $233,539,722.44. This trade represents a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,086,868 shares of company stock worth $66,023,884 in the last three months. Insiders own 14.70% of the company's stock.
Lemonade Stock Down 3.4%
LMND stock traded down $1.27 during mid-day trading on Friday, hitting $36.41. The company had a trading volume of 1,978,518 shares, compared to its average volume of 1,868,202. The company has a market capitalization of $2.67 billion, a price-to-earnings ratio of -11.98 and a beta of 2.19. Lemonade, Inc. has a 12-month low of $14.90 and a 12-month high of $53.85. The company has a 50-day moving average price of $39.58 and a 200 day moving average price of $34.73.
Lemonade (NYSE:LMND - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported ($0.86) earnings per share for the quarter, missing analysts' consensus estimates of ($0.84) by ($0.02). Lemonade had a negative return on equity of 36.72% and a negative net margin of 38.90%. During the same quarter in the prior year, the company earned ($0.67) earnings per share. The business's revenue was up 27.0% compared to the same quarter last year. As a group, analysts expect that Lemonade, Inc. will post -3.03 EPS for the current year.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on LMND shares. Morgan Stanley reissued an "underweight" rating and set a $26.00 price objective (up previously from $24.00) on shares of Lemonade in a research report on Monday, July 14th. BMO Capital Markets lifted their target price on shares of Lemonade from $15.00 to $23.00 and gave the company an "underperform" rating in a research note on Wednesday, July 2nd. Keefe, Bruyette & Woods restated an "underperform" rating and set a $26.00 target price (up previously from $22.00) on shares of Lemonade in a research note on Tuesday, July 1st. Finally, Wall Street Zen cut shares of Lemonade from a "hold" rating to a "sell" rating in a research note on Saturday, July 26th. Five research analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Lemonade currently has an average rating of "Reduce" and a consensus target price of $30.50.
Read Our Latest Stock Analysis on Lemonade
Lemonade Company Profile
(
Free Report)
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
See Also

Before you consider Lemonade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.
While Lemonade currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.